Federal and State Legislative and Regulatory Issues
Please see the Inside this Section box to the left for more information
- Federal and state legislation and regulations.
- Find tools and information here.
- Influence the issues that matter to you.
Contact your State Advocacy Coordinator to get involved in advocacy efforts in your state.
- Biosimilar and Interchangeable Drug Products Legislation and Laws
Biosimilar and Interchangeable Drug Products Legislation and Laws as of July, 2018Read More »
- Drug Pricing Summary and Legislation
September 2018 OVERVIEW AMCP is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. AMCP supports efforts to reduce drug prices by encouraging both meaningful transparency within healthRead More »
- Final Compromise Opioid Legislation Announced
Opioid Legislation Reaches Final Agreement--September 2018 With a final compromise bill for the opioid package announced, AMCP would like to thank its members who acted to advocate for the inclusion of provisions which will help managed care combat the opioid crisis. Almost 300 AMCP members sent letters to 62 SenatorsRead More »
- House Passes Opioid Legislation
Opioid Legislation Passed by the U.S. House of Representatives -- June 2018 During the month of June, the House of Representatives passed more than 70 opioid related bills. One of AMCP’s policy and advocacy focus areas for 2018 is opioid management. AMCP also approved a new policy digest statement on Opioid ManagRead More »
- Opioid Summary and Legislation
July 2018 OVERVIEW One of AMCP’s policy and advocacy focus areas for 2018 is Opioid Management. AMCP has been actively involved on the federal and state levels to increase awareness of the role of managed care pharmacy in support of patient-centered and clinically effective approaches to reduce overuse, diversion, andRead More »